Patent details
LUC00038 Product Name: pibrentasvir ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- LUC00038
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP131910416
- Legal Status:
- Inactive
- Application number:
- LUC00038
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 23/09/2021
- SPC Extension Agent Name:
- OFFICE FREYLINGER S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 05/06/2024
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/17/1213
- Marketing Authorization Type:
- Marketing Authorization Date:
- 28/07/2017
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 10/10/2017
- First Marketing Authorization date:
- 28/07/2017
- Grant date:
- 13/12/2017
- Activation date:
- Publication date:
- 12/10/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 28/07/2032
- SPC Extension Expiration:
- 28/01/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 26/03/2024
- Name:
- ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY
- Address:
- 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)
History of Owners
- From:
- 26/03/2024
- To:
- 26/03/2024
- Name:
- ABBVIE IRELAND UNLIMITED COMPANY
- Address:
- 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)
- From:
- 10/10/2017
- To:
- 26/03/2024
- Name:
- AbbVie Bahamas Ltd.
- Address:
- Sassoon House, Shirley Street & Victoria Avenue, New Providence, Nassau, Bahamas (BS)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 10/10/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2017/07
- Publication date:
- 11/12/2017
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2021/11
- Publication date:
- 08/10/2021
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
4
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2024/05
- Publication date:
- 03/04/2024
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
5
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2024/05
- Publication date:
- 03/04/2024
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
6
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2024/09
- Publication date:
- 11/07/2024
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20240000143A
- Date Registered:
- 26/03/2024
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- ABBVIE IRELAND UNLIMITED COMPANY
- Address:
- 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)
Removed Pledgee
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20240000145A
- Date Registered:
- 26/03/2024
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY
- Address:
- 70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/10/2031
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 23/09/2021 | Paediatric investigation plan | 1 |
| 10/10/2017 | Application Form | 4 |
| 13/12/2017 | Publication | 1 |
| 23/09/2021 | Marketing authorization | 3 |
| 12/10/2017 | Outgoing Correspondence | 1 |
| 23/09/2021 | Outgoing Correspondence | 1 |
| 23/09/2021 | Application Form | 3 |
| 23/09/2021 | Paediatric investigation plan | 4 |
| 23/09/2021 | Summary of the product caracteristics | 81 |
| 10/10/2017 | Description | 39 |
| 13/12/2017 | Certificate | 1 |
| 13/12/2017 | FNET_DC_FRONTPAGE | 1 |
| 12/10/2017 | Publication | 1 |
| 10/10/2017 | General Document | 3 |
| 10/10/2017 | General Document | 3 |
| 23/09/2021 | General Document | 2 |
| 26/03/2024 | Request For Change | 19 |
| 28/03/2024 | Outgoing Correspondence | 2 |
| 26/03/2024 | Request For Change | 16 |
| 28/03/2024 | Outgoing Correspondence | 2 |
| 23/09/2021 | Publication | 1 |
| 05/06/2024 | Publication | 1 |
| 05/06/2024 | Certificate | 1 |
| 23/09/2021 | FNET_DC_FRONTPAGE | 1 |
| 06/06/2024 | Outgoing Correspondence | 1 |